Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
18,892 total articles
First National Corporation (NASDAQ: FXNC), the bank holding company of First Bank, reported net income of $4.9 million and diluted earnings per share of $0.54 for Q1 2026. The company exceeded budgeted metrics despite a challenging start, driven by increased loan production in March and strong deposit growth at an 8.4% annualized rate. Asset qualit…
Banco Santander Chile released its first quarter 2026 financial results, showcasing a solid performance with a 7.0% quarter-over-quarter profit growth and a return on average equity (ROAE) of 23.0%. The bank demonstrated growth in customer base and fees, effective expense management leading to improved efficiency, and maintained strong capital rati…
Rezolve Ai reported an outstanding Q1 2026 revenue of $60 million, exceeding its total 2025 revenue of $46.8 million in just three months. This performance supports its $360 million revenue guidance for 2026 and signals rapid scaling of its AI-driven commerce platform. The company highlighted expanding enterprise adoption, strategic partnerships, a…
GrowGeneration Corp., a leading supplier of specialty products for controlled environment agriculture and commercial cultivation, will release its Q1 2026 financial results on May 12, 2026, accompanied by a live earnings call. The company highlighted its diverse product offerings and proprietary brands, as well as its online and wholesale business …
Nature's Sunshine Products, Inc., a NASDAQ-listed leader in herbal and nutritional supplements, announced the appointment of John Hnanicek as Chief Technology Officer effective May 4, 2026. Hnanicek brings extensive experience in technology leadership and digital transformation from previous roles at Melaleuca and The Vitamin Shoppe, aiming to mode…
Picard Medical, Inc., parent company of SynCardia Systems, highlights Banner Health's global leadership and extensive clinical experience in total artificial heart (TAH) therapy, having performed over 50 SynCardia Total Artificial Heart implants. The partnership underscores advancements in treating end-stage biventricular heart failure patients as …
Lexicon Pharmaceuticals, a biopharmaceutical company focused on pioneering medicines for neuropathic pain, cardiometabolic diseases, and obesity, announced it will report its first quarter 2026 financial results on May 7, 2026, prior to market open. The company will also host a conference call and webcast to discuss the results and provide a busine…
INmune Bio Inc., a clinical-stage biotechnology company focusing on treatments targeting the innate immune system, announced it will release its financial results for Q1 2026 on May 7, 2026, along with a corporate update via conference call and webcast. The company has ongoing clinical programs targeting neuroinflammation related to Alzheimer's Dis…
Krystal Biotech, Inc. (NASDAQ: KRYS), a commercial-stage biotechnology company specializing in genetic medicines, announced it will present new data and progress on several gene therapy programs at key scientific meetings in May and June 2026. The presentations cover treatments for primary ciliary dyskinesia, cystic fibrosis, and advanced non-small…
Retail Rush, an online buy-online pick-up-in-store consumer auction marketplace operated by Liquidity Services, has reached a $4 million annual revenue run rate since its September 2025 launch in Columbus, Ohio. Retail Rush's model of daily online auctions combined with local pickup has attracted a growing base of repeat customers and offers signif…
Xcel Brands, a media and consumer products company specializing in influencer-led brands and social commerce, has announced the sale of its luxury fine jewelry brand Judith Ripka for approximately $3 million. The company aims to focus on building influencer-led brands and leveraging its expertise in live-streaming commerce.
Red Violet, Inc., a provider of analytics and identity intelligence solutions, announced its participation in the 21st Annual Needham Technology, Media & Consumer Conference, where its CEO and CFO will present and host investor meetings virtually on May 14, 2026. The company offers cloud-native AI-embedded platforms for identity verification, risk …
ProQR Therapeutics announced the nomination of Dr. Lykke Hinsch Gylvin, Chief Medical Officer at Boehringer Ingelheim, to its Board of Directors. Dr. Hinsch Gylvin brings extensive experience in global drug development across multiple therapeutic areas. Her appointment is expected to support ProQR's continued advancement of its proprietary Axiomer …
Emergent BioSolutions has received approval from the Singapore Health Sciences Authority for an expanded indication of its ACAM2000 vaccine to include prevention of mpox disease in adults at high risk. This milestone broadens the vaccine's authorized use to support public health preparedness against mpox outbreaks in Singapore, reinforcing Emergent…
MoneyHero Limited, a Nasdaq-listed fintech company operating in Southeast Asia, announced its unaudited Q4 and audited full year 2025 results, highlighting a significant turnaround with the first quarterly net profit of $0.5 million and an Adjusted EBITDA gain of $0.7 million. The company achieved revenue growth driven by higher-margin products lik…
Aebi Schmidt Holding AG, a global leader in specialty vehicles, will release its first quarter 2026 financial results before market open on May 14, 2026. The company will also hold a webcast and live conference call for investors and analysts. Headquartered in Switzerland and listed on NASDAQ, Aebi Schmidt operates across Europe and North America, …
CCC Intelligent Solutions Holdings Inc. announced that CFO Brian Herb will depart in May 2026, with Rodney Christo stepping in as interim CFO. The company also reported strong Q1 2026 financial results, with 12% revenue growth and 21% adjusted EBITDA growth compared to Q1 2025, reinforcing its growth trajectory in the insurance technology sector.
Roadzen Inc. (Nasdaq: RDZN) announced a non-binding Letter of Intent with a leading U.S. commercial insurance carrier to secure $30 million in underwriting capacity for a new commercial auto insurance program, expected to scale to $50 million over three years. Backed by over $50 million in committed premium demand from its U.S. producer network, th…
Parker Hannifin Corporation reported strong fiscal 2026 third quarter results, with record sales of $5.5 billion, up 11% year-over-year. Adjusted net income and EPS rose 16% and 18% respectively, driven by solid organic sales growth, strong order rates, and improved segment operating margins. The company increased its full-year guidance, expecting …
Yuanbao Inc., a Nasdaq-listed technology-driven online insurance distributor in China, announced the filing of its annual report on Form 20-F for fiscal year 2025 with the U.S. Securities and Exchange Commission. The report includes audited consolidated financial statements and is accessible via the company's investor relations website. Yuanbao ser…
FTI Consulting announced first quarter 2026 financial results featuring a 9.5% increase in revenues to $983.3 million and a 9.2% increase in EPS to $1.90 compared to the prior year quarter. Despite higher revenues, net income declined due to increased costs, higher SG&A expenses, interest expense, and a higher tax rate. The company reaffirmed its f…
Palvella Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel therapies for rare skin diseases and vascular malformations, will report its Q1 2026 financial results on May 7, 2026. The company will hold a conference call to discuss the results and corporate update. Palvella's lead products are investigational therapi…
TG Therapeutics, a commercial-stage biotechnology company focusing on B-cell disease treatments, announced a conference call on May 6, 2026, to discuss first quarter financial results and provide a business update for the remainder of 2026. The company recently obtained FDA approval for BRIUMVI for treating relapsing multiple sclerosis and continue…
Helus Pharma announced that Interim CEO Eric So will participate in a panel on health innovation at the 29th Annual Milken Institute Global Conference. The company is developing novel serotonergic agonists (NSAs) for mental health conditions including major depressive disorder and generalized anxiety disorder, with some products in advanced clinica…
Saia, Inc. reported first quarter 2026 financial results with revenue rising 2.4% to $806.2 million, while diluted EPS remained flat at $1.86 compared to Q1 2025. Operating income decreased 4.8%, reflecting a slightly higher operating ratio and lower LTL tonnage per workday despite increased shipments. The company continues investing in its nationa…
